How to Report Deviations in Final Stability Reports
In pharmaceutical stability programs, maintaining data integrity is a non-negotiable requirement. Deviations—especially those caused by equipment failure—must be transparently documented and accurately reported in final stability reports. Regulatory authorities like the USFDA and EMA scrutinize these reports to assess whether the reported product data reflects true storage conditions and is suitable for approval or continued…
Read More “How to Report Deviations in Final Stability Reports” »
